Cite
Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007. Bull Exp Biol Med. 2009;147(5):669doi: 10.1007/s10517-009-0584-1.
(2009). Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007. Bulletin of experimental biology and medicine, 147(5), 669. https://doi.org/10.1007/s10517-009-0584-1
"Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007." Bulletin of experimental biology and medicine vol. 147,5 (2009): 669. doi: https://doi.org/10.1007/s10517-009-0584-1
Retraction notice. "Genetic aberrations in tissue inhibitor of metalloproteinases-3 lead to manifestations of the myofibroblast phenotye in mouse fibroblasts and fibroblasts of patients with Sorsby fundus dystrophy" by G. M. Soboleva and G. T. Sukhikh, Vol. 143, No. 2, pp. 231-235, February 2007. Bull Exp Biol Med. 2009 May;147(5):669. doi: 10.1007/s10517-009-0584-1. PMID: 20082502.
Copy
Download .nbib
